Oramed Pharmaceuticals (ORMP) Q4 2025 Annual Earnings — Beat Estimates

Screener

Reported March 26, 2026 · After market close

EPS-$0.06Beat by $0.02

Revenue estimate$500.0K

EPS estimate-$0.08

Next report

Nov 12, 2026 (in 2 months)

EPS estimate$0.43

Versus estimates

Revenue

Diluted EPS

Q2 2026-$0.09Miss by $0.52 Q1 2026-$0.16

Q4 2025-$0.06Beat by $0.02

Q3 2025$1.13Beat by $1.17 Q2 2025-$0.05Miss by $0.01 Q1 2025-$0.19Miss by $0.16

FAQ

When did Oramed Pharmaceuticals report Q4 2025 earnings?: Oramed Pharmaceuticals (ORMP) reported Q4 2025 earnings on March 26, 2026 after market close.
What were Oramed Pharmaceuticals's Q4 2025 revenue and EPS?: Oramed Pharmaceuticals reported eps of $-0.06 for Q4 2025.
Did Oramed Pharmaceuticals beat estimates in Q4 2025?: EPS beat the consensus estimate of $-0.08 by $0.02.
Where can I find Oramed Pharmaceuticals's Q4 2025 SEC filings?: You can read the 10-K periodic report (0001213900-26-034835) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ask the moment Oramed Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk